Elyana Matayeva

481 citations
7 papers · 387 indexed · h-index 3
Topics
Monoclonal and Polyclonal Antibodies Research (3 papers)T-cell and B-cell Immunology (3 papers)Immunotherapy and Immune Responses (3 papers)
Partner nations
United States

In The Last Decade

Elyana Matayeva

4 papers receiving 385 citations

Peers

Elyana Matayeva
Comparison fields: 5 of 55
  • Immunology 328
  • Oncology 95
  • Molecular Biology 91
  • Radiology, Nuclear Medicine and Imaging 75
  • Hematology 38
Replace A. Moretta with:
A. Moretta Italy
B.A. Van Krimpen Netherlands
Valéry Renard France
Dianne H. Wilson United States
PM Anderson United States
Michela Cesco-Gaspere United Kingdom
G Dennert United States
Hilma J. van der Horst Netherlands
Harald Bradl Germany
Masaru Taniguchi Japan
Elyana Matayeva relative to A. Moretta Italy A. Moretta's profile →
Citations per field
00.5×10×
A. Moretta · 1×
Citations per year

Countries citing papers authored by Elyana Matayeva

Since Specialization
Citations

This map shows the geographic impact of Elyana Matayeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elyana Matayeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elyana Matayeva more than expected).

Fields of papers citing papers by Elyana Matayeva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elyana Matayeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elyana Matayeva. The network helps show where Elyana Matayeva may publish in the future.

Co-authorship network of co-authors of Elyana Matayeva

This figure shows the co-authorship network connecting the top 25 collaborators of Elyana Matayeva. A scholar is included among the top collaborators of Elyana Matayeva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elyana Matayeva. Elyana Matayeva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 26
5 115
6 1
7 245

About Elyana Matayeva

Elyana Matayeva is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 7 papers that have together received 387 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (3 papers), T-cell and B-cell Immunology (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Immunology (328 citations), Oncology (95 citations) and Hematology (38 citations). Elyana Matayeva has collaborated with scholars based in United States. Frequent co-authors include Devi Banerjee, Ralph M. Steinman, Kavita M. Dhodapkar, Madhav V. Dhodapkar, Maria Veri, Anjli Kukreja, John E. Connolly, Jeffrey V. Ravetch, John F. Connolly and Sarah Malik. Their work appears in journals such as The Journal of Experimental Medicine, Blood and CHEST Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026